Cargando…

Assessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study protocol

INTRODUCTION: Despite therapeutic advances, many people with type 1 diabetes are still unable to achieve optimal glycaemic control, limited by the occurrence of hypoglycaemia. The objective of the present study is to determine the effectiveness of day and night home closed-loop over the medium term...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leelarathna, Lalantha, Dellweg, Sibylle, Mader, Julia K, Barnard, Katharine, Benesch, Carsten, Ellmerer, Martin, Heinemann, Lutz, Kojzar, Harald, Thabit, Hood, Wilinska, Malgorzata E, Wysocki, Tim, Pieber, Thomas R, Arnolds, Sabine, Evans, Mark L, Hovorka, Roman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Diabetes and Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158197/ https://www.ncbi.nlm.nih.gov/pubmed/25186158 http://dx.doi.org/10.1136/bmjopen-2014-006075

Ejemplares similares

Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes
por: Emami, Ali, et al.
Publicado: (2017)

Faster insulin action is associated with improved glycaemic outcomes during closed‐loop insulin delivery and sensor‐augmented pump therapy in adults with type 1 diabetes
por: Ruan, Yue, et al.
Publicado: (2017)

Hypoglycaemia incidence and recovery during home use of hybrid closed‐loop insulin delivery in adults with type 1 diabetes
por: Ruan, Yue, et al.
Publicado: (2018)

Bolusing frequency and amount impacts glucose control during hybrid closed‐loop
por: Bally, L., et al.
Publicado: (2017)

Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions
por: Thabit, Hood, et al.
Publicado: (2015)

Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol
por: Bally, Lia, et al.
Publicado: (2017)

Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study
por: Bally, Lia, et al.
Publicado: (2017)

Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study
por: Boughton, Charlotte K, et al.
Publicado: (2022)

Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study
por: Lawton, Julia, et al.
Publicado: (2019)

Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents
por: Barnard, Katharine D, et al.
Publicado: (2014)

Basal insulin delivery reduction for exercise in type 1 diabetes: finding the sweet spot
por: Thabit, Hood, et al.
Publicado: (2016)

COVID-19: Impact of and on Diabetes
por: Schofield, Jonathan, et al.
Publicado: (2020)

Impact of the CamAPS FX hybrid closed‐loop insulin delivery system on sleep traits in older adults with type 1 diabetes
por: Thabit, Hood, et al.
Publicado: (2022)

Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol
por: Wilmot, Emma G, et al.
Publicado: (2021)

Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
por: Tauschmann, Martin, et al.
Publicado: (2018)

Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial
por: Leelarathna, Lalantha, et al.
Publicado: (2013)

Day and Night Closed-Loop Control in Adults With Type 1 Diabetes: A comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management
por: Luijf, Yoeri M., et al.
Publicado: (2013)

Modelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery
por: Ruan, Yue, et al.
Publicado: (2015)

Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial
por: Hovorka, Roman, et al.
Publicado: (2014)

Reduced burden of diabetes and improved quality of life: Experiences from unrestricted day‐and‐night hybrid closed‐loop use in very young children with type 1 diabetes
por: Musolino, Gianluca, et al.
Publicado: (2019)

Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England
por: Prabhu Navis, Joshi, et al.
Publicado: (2020)

Factors Associated With Glycemic Control During Free-Living Overnight Closed-Loop Insulin Delivery in Children and Adults With Type 1 Diabetes
por: Tauschmann, Martin, et al.
Publicado: (2015)

The impact of using a closed‐loop system on food choices and eating practices among people with Type 1 diabetes: a qualitative study involving adults, teenagers and parents
por: Lawton, J., et al.
Publicado: (2019)

Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care
por: Carr, Matthew J, et al.
Publicado: (2022)

Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK
por: Carr, Matthew J, et al.
Publicado: (2021)

Coming of age: the artificial pancreas for type 1 diabetes
por: Thabit, Hood, et al.
Publicado: (2016)

Continuous glucose monitoring in critically ill adults: comparison of two different calibration protocols
por: Leelarathna, L, et al.
Publicado: (2013)

Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocol
por: Fuchs, Julia, et al.
Publicado: (2021)

Closed-loop for type 1 diabetes – an introduction and appraisal for the generalist
por: Bally, Lia, et al.
Publicado: (2017)

Real-World Outcomes of Glucose Sensor Use in Type 1 Diabetes—Findings from a Large UK Centre
por: Lee, Kyuhan, et al.
Publicado: (2021)

Sensor Life and Overnight Closed Loop: A Randomized Clinical Trial
por: Tauschmann, Martin, et al.
Publicado: (2016)

Computer-advised insulin infusion in postoperative cardiac surgery patients: a randomized prospective controlled multicenter trial
por: Cordingley, J, et al.
Publicado: (2006)

Space GlucoseControl with the incorporated enhanced model predictive control algorithm is a safe and reliable tool for glycaemic control in medical ICU patients
por: Amrein, K, et al.
Publicado: (2011)

Pharmacokinetics of Insulin Aspart in Pump-Treated Subjects With Type 1 Diabetes: Reproducibility and Effect of Age, Weight, and Duration of Diabetes
por: Haidar, Ahmad, et al.
Publicado: (2013)

Unsupervised home use of an overnight closed‐loop system over 3–4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes
por: Thabit, H., et al.
Publicado: (2015)

Closed-Loop Basal Insulin Delivery Over 36 Hours in Adolescents With Type 1 Diabetes: Randomized clinical trial
por: Elleri, Daniela, et al.
Publicado: (2013)

Nocturnal antihypertensive treatment in patients with type 1 diabetes with autonomic neuropathy and non-dipping of blood pressure during night time: protocol for a randomised, placebo-controlled, double-blind, two-way crossover study
por: Hjortkær, Henrik, et al.
Publicado: (2014)

Psychosocial Aspects and Diabetes Technology – Head to Head or Hand in Hand?
por: Barnard, Katharine D, et al.
Publicado: (2016)

Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin: A proof-of-concept study
por: Arnolds, Sabine, et al.
Publicado: (2010)

Mixed‐meal tolerance test to assess residual beta‐cell secretion: Beyond the area‐under‐curve of plasma C‐peptide concentration
por: Ruan, Yue, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n0pr2l3m8mi1gcj3glftve95qn